Evolent Health, Inc. Provides Earnings Guidance for the Third Quarter Ending September 30, 2023 and Reiterates Earnings Guidance for the Full Year Ending December 31, 2023
August 02, 2023 at 04:10 pm
Share
Evolent Health, Inc. provided earnings guidance for the third quarter ending September 30, 2023 and reiterated earnings guidance for the full year ending December 31, 2023. For the third quarter ending September 30, 2023, the company's revenue is expected to be in the range of approximately $500 million to $520 million.
For the full year ending December 31, 2023, The company is reiterating its previously-stated guidance for revenue and expects to be in the range of approximately $1.935 billion to $1.965 billion.
Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers three primary solutions: specialty care management services, total cost of care management and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advance care planning services as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.
Evolent Health, Inc. Provides Earnings Guidance for the Third Quarter Ending September 30, 2023 and Reiterates Earnings Guidance for the Full Year Ending December 31, 2023
EVOLENT HEALTH, INC. 
